Skip to main content

Table 2 Characteristics of Oji-Cree type 2 diabetic patients according to MTHFR 677C>T genotype (max n = 138)

From: Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes

 

N

677C/C

677C/T

P

N (men/women)

138

108 (41/67)

30 (8/22)

NS (0.25)

Age (years)

138

46.4 ± 11.1

45.1 ± 13.5

NS (0.60)

BMI (kg/m2)

137

29.7 ± 4.7

32.6 ± 5.5

0.0050

Waist circumference (cm)

137

103 ± 9

106 ± 11

NS (0.063)

Current smoker (%)

138

50.0

50.0

NS (1.00)

Duration of diabetes (years)

138

8.53 ± 6.35

9.20 ± 7.01

NS (0.62)

Fasting glucose (mmol/L)

130

10.20 ± 3.91

9.28 ± 3.03

NS (0.33)

HbA1c (%)

136

8.36 ± 2.25

8.66 ± 2.18

NS (0.47)

Total cholesterol (mmol/L)

133

4.91 ± 1.07

4.67 ± 0.82

NS (0.27)

HDL-C (mmol/L)

133

1.21 ± 0.29

1.21 ± 0.29

NS (0.91)

LDL-C (mmol/L)

130

2.75 ± 0.71

2.70 ± 0.67

NS (0.78)

Plasma triglycerides (mmol/L)

133

2.20 ± 2.78

1.66 ± 0.60

NS (0.15)

Systolic BP (mmHg)

138

123 ± 16

132 ± 22

0.021

Diastolic BP (mmHg)

138

73.9 ± 8.9

77.4 ± 9.4

NS (0.077)

Hypertensive (%)

138

62.0

66.7

NS (0.64)

CRP (mg/L)

133

4.91 ± 6.65

6.53 ± 8.37

NS (0.19)

ABI, left

138

1.08 ± 0.09

1.05 ± 0.12

NS (0.26)

ABI, right

138

1.08 ± 0.09

1.07 ± 0.13

NS (0.73)

  1. Data are means ± s.d., unless otherwise indicated.
  2. Hypertension: systolic BP ≥ 130 and/or diastolic BP ≥ 80 and/or antihypertensive treatment
  3. Abbreviations: BMI, body mass index; HbA1c, glycosylated hemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; BP, blood pressure; CRP, C-reactive protein; ABI, ankle-brachial index; NS, not significant.